Are you Dr. Zipkin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 68 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
50 S San Mateo Dr
San Mateo, CA 94401Phone+1 650-652-8600Fax+1 650-696-5258
Summary
- Dr. Robert Zipkin, MD is a cardiologist in San Mateo, California. He is currently licensed to practice medicine in California. He is affiliated with Mills-Peninsula Medical Center.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1988 - 1991
- Kaiser Permanente Northern California (San Francisco)Residency, Internal Medicine, 1987 - 1988
- California Pacific Medical CenterResidency, Internal Medicine, 1985 - 1987
- University of California Davis HealthInternship, Internal Medicine, 1984 - 1985
- University of California, Davis, School of MedicineClass of 1984
Certifications & Licensure
- CA State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
Publications & Presentations
PubMed
- 20 citationsN-arachidonoyl glycine, another endogenous agonist of GPR55.Linda M. Console-Bram, Sandra M. Ciuciu, Pingwei Zhao, Robert E. Zipkin, Eugen Brailoiu
Biochemical and Biophysical Research Communications. 2017-09-02 - 153 citationsTARGETING SPHINGOSINE KINASE 1 INHIBITS AKT SIGNALING, INDUCES APOPTOSIS, AND SUPPRESSES GROWTH OF HUMAN GLIOBLASTOMA CELLS AND XENOGRAFTSDmitri Kapitonov, Jeremy C. Allegood, Clint Mitchell, Nitai C. Hait, Jorge A. Almenara
Cancer Research. 2009-09-01 - 197 citationsA selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemiaSteven W. Paugh, Barbara S. Paugh, Mohamed Rahmani, Dmitri Kapitonov, Jorge A. Almenara
Blood. 2008-08-15
Grant Support
- Tyrosine Phosphatase Inhibitors As New ImmunomodulatorsNational Institute Of Allergy And Infectious Diseases1993
- Farnesyltransferase Inhibitors As Anticancer AgentsNational Cancer Institute1993
- Novel Anticancer Drugs Based On Glycolipid DepletionNational Cancer Institute1992
- Novel Therapeutic Agents For Myocardial InfarctionNational Heart, Lung, And Blood Institute1990
- Radioimmunoassay Kits For Platelet Activating FactorNational Heart, Lung, And Blood Institute1988
- Radioimmunoassay Kits For Leukotriene MetabolitesNational Heart, Lung, And Blood Institute1986
Other Languages
- Spanish, French, Hebrew